[go: up one dir, main page]

DE60140552D1 - Transglutaminase genprodukte - Google Patents

Transglutaminase genprodukte

Info

Publication number
DE60140552D1
DE60140552D1 DE60140552T DE60140552T DE60140552D1 DE 60140552 D1 DE60140552 D1 DE 60140552D1 DE 60140552 T DE60140552 T DE 60140552T DE 60140552 T DE60140552 T DE 60140552T DE 60140552 D1 DE60140552 D1 DE 60140552D1
Authority
DE
Germany
Prior art keywords
gene products
transglutaminase gene
nucleotides
transglutaminase
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60140552T
Other languages
English (en)
Inventor
Daniel Peter Aeschlimann
Pascale Marie Grenard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zedira GmbH
Original Assignee
Zedira GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0022768A external-priority patent/GB0022768D0/en
Priority claimed from GB0111995A external-priority patent/GB0111995D0/en
Application filed by Zedira GmbH filed Critical Zedira GmbH
Application granted granted Critical
Publication of DE60140552D1 publication Critical patent/DE60140552D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60140552T 2000-09-15 2001-09-14 Transglutaminase genprodukte Expired - Lifetime DE60140552D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0022768A GB0022768D0 (en) 2000-09-15 2000-09-15 Transglutaminase gene products
GB0111995A GB0111995D0 (en) 2001-05-16 2001-05-16 Transglutaminase gene products
PCT/GB2001/004120 WO2002022830A2 (en) 2000-09-15 2001-09-14 Transglutaminase gene products

Publications (1)

Publication Number Publication Date
DE60140552D1 true DE60140552D1 (de) 2009-12-31

Family

ID=26245015

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60140552T Expired - Lifetime DE60140552D1 (de) 2000-09-15 2001-09-14 Transglutaminase genprodukte

Country Status (7)

Country Link
US (1) US7052890B2 (de)
EP (1) EP1317548B1 (de)
AT (1) ATE449180T1 (de)
AU (1) AU2001287860A1 (de)
DE (1) DE60140552D1 (de)
DK (1) DK1317548T3 (de)
WO (1) WO2002022830A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887695B2 (en) * 2001-03-28 2005-05-03 Zymogenetics, Inc. Transglutaminase ztg2
ATE511651T1 (de) * 2007-04-06 2011-06-15 Zedira Gmbh Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen
US20130109107A1 (en) * 2010-05-25 2013-05-02 The Regents Of The University Of Colorado Diagnosis and treatment of autoimmune disease
WO2025235822A1 (en) * 2024-05-10 2025-11-13 Gmp Biotechnology Limited Therapeutics for cancer using tgfb2 and tgm6

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5590394A (en) 1992-11-03 1994-05-24 Oklahoma Medical Research Foundation Transglutaminase gene
US5470957A (en) * 1993-10-01 1995-11-28 President And Fellows Of Harvard College Immunoinhibitors of factor XIII
US6114119A (en) 1997-08-29 2000-09-05 Wisconsin Alumni Research Foundation Transglutaminase and gene encoding same

Also Published As

Publication number Publication date
DK1317548T3 (da) 2010-03-08
EP1317548B1 (de) 2009-11-18
US20040072186A1 (en) 2004-04-15
WO2002022830A2 (en) 2002-03-21
WO2002022830A3 (en) 2002-10-24
EP1317548A2 (de) 2003-06-11
US7052890B2 (en) 2006-05-30
AU2001287860A1 (en) 2002-03-26
ATE449180T1 (de) 2009-12-15

Similar Documents

Publication Publication Date Title
ES2154624T1 (es) Regulacion de la expresion de la quinolato fosforribosil transferasa.
DE69403642D1 (de) 7-deazapurin modifizierte oligonukleotide
EP1490489A4 (de) Verfahren und mittel zur überwachung und modulation des gen-silencing
DE60112746D1 (de) Kälteempfindliche dna-polymerasemutanten
HUP0402271A2 (hu) Pseudoplectania nigrellá-ból származó antimikrobiális polipeptidek
WO2001047944A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
ATE471370T1 (de) Varianten von beta-glukosidasen
ATE239090T1 (de) Methode zum generieren von einzelsträngigen dna molekülen
IL158415A0 (en) NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha-17 GENE
ATE196926T1 (de) Gen grb3-3, variante und ihre verwendungen
WO1999028439A3 (fr) Erythrovirus et ses applications
ATE449180T1 (de) Transglutaminase genprodukte
WO2001040521A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001048245A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
DE50111824D1 (de) Diagnose von mit humos assoziierten krankheiten
WO2002101048A3 (en) NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
ATE284960T1 (de) Nukleotid sequenzen kodierend für das lysr3 gen
ATE303444T1 (de) Nukleinsäuren kodierend für das tmk gen
DK1226236T3 (da) Polypeptider, der har glucanotransferase-aktivitet, og nucleinsyrer, som koder disse
WO2002083733A3 (en) Polynucleotides and polypeptides of the ifnalpha-6 gene
IT1320168B1 (it) Oligonucleotidi sintetici in grado di indurre il differenziamentoeritroide.
WO2000029622A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2002083727A3 (de) Nukleinsäuresequenzen von hyperplasien und tumoren der schilddrüse
WO2001051670A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
ATE332981T1 (de) Einzelsträngige oligonukleotide, sonden, primer und ein vefahren zur detektion von spirochaeten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition